Heterocycles in Drug Discovery
A topical collection in Drugs and Drug Candidates (ISSN 2813-2998). This collection belongs to the section "Medicinal Chemistry and Preliminary Screening".
Viewed by 16Editors
Interests: chemistry of heterocyclic compounds; microwave-assisted chemistry; sustainable methodologies; green chemistry applied to bioactive compounds: kinase inhibitors; Alzheimer's disease; down syndrome; cancer
Special Issues, Collections and Topics in MDPI journals
2. APHM, Pharmacy Department, Service Central de la Qualité et de l'Information Pharmaceutiques, 147 Bd Baille, 13005 Marseille, France
Interests: medicinal chemistry; heterocyclic chemistry; Plasmodium; Leishmania; Trypanosoma; nitroheterocycles
Special Issues, Collections and Topics in MDPI journals
Topical Collection Information
Dear Colleagues,
Heterocycles are crucial in drug discovery due to their high prevalence in biologically active compounds and pharmaceuticals. These ring structures, containing at least one atom other than carbon (commonly nitrogen, oxygen, or sulfur), constitute a unique opportunity to modulate diverse chemical and physical properties that enhance the interaction with biological targets. Their versatility allows for the design of molecules with improved potency, selectivity, and pharmacokinetic profiles. Many drugs, including antibiotics, antivirals, anticancer agents, and CNS drugs, feature heterocyclic moiety, underscoring their importance in the drug discovery process for developing effective and innovative therapeutics.
Prof. Dr. Thierry Besson
Dr. Nicolas Primas
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Drugs and Drug Candidates is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug discovery
- heterocycles
- medicinal chemistry
- bioisosteres
- physicochemical properties
- ADMET
- pharmacophore
- drug design
